Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Rev Sci Instrum ; 88(3): 033508, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28372397

RESUMEN

A new high speed gas valve was developed for disruption mitigation studies in the tokamak ASDEX Upgrade. The valve was designed to operate inside the vacuum vessel to reduce the time of flight of the injected gas and to prevent dispersion of the gas cloud before the gas reaches the plasma. A spring-driven mechanism was chosen for the valve as it is robust against the high magnetic fields and electromagnetic disturbances inside the vessel. The internal gas reservoir (128 cm3) of the valve, which holds the mitigation gas, is opened within 1.5 ms, and the maximal stroke between the valve plate and nozzle (diameter 13 mm) is 4.5 mm. This allows a peak flow rate of 72 kPam3/s after 1 ms which was determined both analytically and numerically. The highest gas velocity (approximately 560 m/s) is reached 0.6 ms after the valve is opened. The gas cloud expands in a pear shape with an opening angle of 49°.

2.
Aliment Pharmacol Ther ; 34(7): 799-807, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21793864

RESUMEN

BACKGROUND: Increased gastro-oesophageal reflux (GER) is common in patients with cystic fibrosis (CF). Previous studies showed delayed gastric emptying (GE) and a high prevalence of bile acids in saliva suggesting duodenogastro-oesophageal reflux (DGER). AIM: To assess different types of reflux (acid, weakly acidic and bile) and their relationship with rate of GE in adult CF patients. METHODS: Gastric emptying was assessed in 33 CF patients using breath tests, reflux was monitored in 42 patients using impedance-pH-metry and 14 CF patients underwent combined impedance-pH-Bilitec monitoring. RESULTS: Delayed GE was found in 33%, increased GER (predominantly acid) in 67% and pathological DGER in 35% of the CF patients. There was a significant correlation between oesophageal bile and acid exposure (P < 0.0001, r = 0.85). Patients with increased DGER had a higher proximal extent of reflux compared to those without DGER [17 (9-35) vs. 5 (1-12), P = 0.04]. There was no correlation between GE and reflux parameters, however, in a subgroup of 10 patients studied by impedance-pH-Bilitec and GE, there was a strong correlation between GE rate and bile exposure (P = 0.005, r = 0.83). CONCLUSIONS: Delayed gastric emptying is present in 1/3 of patients with cystic fibrosis. There is a subgroup of these patients with both delayed gastric emptying and increased acidic duodenogastro-oesophageal reflux with high proximal extent and risk of aspiration. Controlled studies should be performed to evaluate the effect of prokinetics or antireflux surgery on the clinical cystic fibrosis evolution in these patients.


Asunto(s)
Fibrosis Quística/complicaciones , Reflujo Duodenogástrico/etiología , Vaciamiento Gástrico/fisiología , Reflujo Gastroesofágico/etiología , Adolescente , Adulto , Ácidos y Sales Biliares/análisis , Pruebas Respiratorias , Fibrosis Quística/fisiopatología , Reflujo Duodenogástrico/fisiopatología , Femenino , Determinación de la Acidez Gástrica , Reflujo Gastroesofágico/fisiopatología , Humanos , Concentración de Iones de Hidrógeno , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Adulto Joven
3.
J Pediatr Gastroenterol Nutr ; 50(2): 161-6, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19966579

RESUMEN

OBJECTIVES: Increased gastroesophageal reflux (GER) is common in children with cystic fibrosis (CF). We studied the occurrence of acid, weakly acidic (WA), and weakly alkaline (WALK) reflux in children with CF and evaluated a possible surrogate marker for risk of gastric content aspiration. PATIENTS AND METHODS: Twenty-four children with CF underwent impedance-pH monitoring for detection of acid (pH < 4), WA (pH 4-7), and WALK-GER (pH > or = 7). In 11 children, cough was objectively recorded with esophageal manometry and the symptom association probability was calculated to determine the reflux-cough relation. Presence of bile acids (BA) was measured in the saliva of 65 patients with CF and 23 healthy children, respectively. RESULTS: Sixteen of the 24 children had increased GER (esophageal acid exposure). The majority of reflux events were acidic in nature. WA reflux was less common and WALK reflux was rare. The sequence reflux-cough was found in 8 of the 11 children and 1 of 11 children had a positive symptom association probability for reflux-cough. The sequence cough-reflux was found in only 3 of the 11 children. Only a small fraction of the total esophageal acid and volume exposure was secondary to cough. Twenty-three of the 65 children with CF had BA in saliva compared with none of the healthy controls. CONCLUSIONS: Although WA-GER is uncommon, acid GER is prevalent in children with CF. It is a primary phenomenon and is not secondary to cough. One third of the children with CF have BA in saliva, which may indicate an increased risk for aspiration. However, the impact of salivary BA and potential aspiration on CF pulmonary disease needs further investigation.


Asunto(s)
Tos/etiología , Fibrosis Quística/complicaciones , Esófago/fisiopatología , Reflujo Gastroesofágico/complicaciones , Aspiración Respiratoria/etiología , Adolescente , Ácidos y Sales Biliares/análisis , Biomarcadores , Niño , Preescolar , Tos/epidemiología , Fibrosis Quística/fisiopatología , Impedancia Eléctrica , Monitorización del pH Esofágico , Femenino , Ácido Gástrico/química , Reflujo Gastroesofágico/fisiopatología , Humanos , Concentración de Iones de Hidrógeno , Lactante , Masculino , Prevalencia , Factores de Riesgo , Saliva/química
4.
Acta Clin Belg ; 63(4): 273-6, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19048707

RESUMEN

Abrikossoff tumours or granular cell tumours are rare and usually benign tumours. The oesophagus is a rare location (0.001% of all tumours). The macroscopic appearance is typical (yellow, firm, well circumscribed submucosal neoplasm-like with reduced vascular patterns) but due to the rarity of this lesion, it can be mistaken with other similar lesions. This is the report of a case of a 47-year-old female with a granular cell tumour of the distal oesophagus. In this case, the Abrikossoff tumour is clinically, radiologically en histologically benign. According to the fact that there is low evidence in the literature for removing such Lesions in patient without symptoms, it was decided to be conservative. In this paper we discuss the case with review of the Literature with emphasis on the diagnosis, evaluation and management.


Asunto(s)
Neoplasias Esofágicas/diagnóstico , Neoplasias Esofágicas/terapia , Tumor de Células Granulares/diagnóstico , Tumor de Células Granulares/terapia , Femenino , Humanos , Persona de Mediana Edad
5.
Gut ; 57(8): 1049-55, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18372497

RESUMEN

BACKGROUND: Gastro-oesophageal reflux (GOR) is increased in cystic fibrosis (CF), but its prevalence, characteristics, association with gastric aspiration and respiratory impact are not well characterised. We investigated acid and weakly acidic reflux, aspiration and respiratory symptoms/function in adult CF patients. METHODS: Thirty-three CF patients [19 men; 29 (18-55) years, [10 post-lung transplant (LTx)] underwent impedance-pH monitoring for detection of acid (pH<4) and weakly acid GOR (pH 4-7). In 16 patients cough was objectively recorded with oesophageal manometry, and the symptom association probability (SAP) was calculated. Saliva and bronchoalveolar lavage fluid (BALF) were tested for bile acids. RESULTS: Twenty-eight patients had increased GOR (21 acid, 5 weakly acidic and 2 acid+weakly acidic) and 10 had a positive SAP for reflux cough. GOR parameters were similar in non-LTx and post-LTx CF patients. The sequence reflux cough was significantly more common than cough reflux. Sixteen of 38 patients had bile acids in saliva and 6/10 in BALF and this was almost exclusively observed in patients with genotype DF508/DF508. Only 12/28 with increased GOR and 9/22 with bile acids in saliva/BALF had typical reflux symptoms. There was a positive correlation (r = 0.53, p = 0.03) between oesophageal acid exposure and cough. SAP-positive patients with for reflux cough had a lower lung function than SAP-negative patients. CONCLUSION: Increased GOR is prevalent in CF and not secondary to cough. Acid GOR is common, but weakly acidic GOR may also occur. CF patients have a high risk of aspiration and reflux seems to be associated with more cough and poorer lung function. Outcome studies with intense anti-reflux therapy are needed to confirm the deleterious role of reflux in CF progression.


Asunto(s)
Fibrosis Quística/complicaciones , Reflujo Gastroesofágico/etiología , Aspiración Respiratoria/etiología , Adolescente , Adulto , Ácidos y Sales Biliares/análisis , Líquido del Lavado Bronquioalveolar/química , Tos/etiología , Fibrosis Quística/metabolismo , Fibrosis Quística/fisiopatología , Fibrosis Quística/cirugía , Femenino , Volumen Espiratorio Forzado , Humanos , Concentración de Iones de Hidrógeno , Trasplante de Pulmón , Masculino , Persona de Mediana Edad , Monitoreo Ambulatorio/métodos , Saliva/química
6.
Eur Respir J ; 31(4): 707-13, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18057058

RESUMEN

Acid gastro-oesophageal reflux (GOR) and gastric aspiration have been labelled as risk factors for chronic rejection bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). The present study aimed to further characterise GOR (both acid and nonacid) and the degree of gastric aspiration in LTx recipients both with and without BOS. Impedance-pH recordings were used for GOR detection. Pepsin and bile acid levels were measured in bronchoalveolar lavage fluid (BALF). A total of 48% of patients had increased GOR, of which 27% had exclusively increased nonacid reflux. Cystic fibrosis patients had the highest prevalence of GOR. Pepsin was found in BALF of all patients and bile acids in BALF of 50% of the patients. Patients with BOS had neither increased GOR nor elevated pepsin in BALF. However, 70% of the patients with BOS had bile in BALF compared with 31% of stable patients. Proton pump inhibitor (PPI) treatment reduced acid reflux but did not affect nonacid reflux. Moreover, pepsin and bile levels in BALF were not reduced by PPI. One-half of the lung transplant patients had increased reflux, and nonacid reflux was common. Gastric aspiration occurred in most lung transplant patients. Pepsin was a more general marker and bile acids a more specific marker that might be associated with bronchiolitis obliterans syndrome. Proton pump inhibitor treatment did not prevent nonacid reflux and gastric aspiration.


Asunto(s)
Bronquiolitis Obliterante , Fibrosis Quística/complicaciones , Reflujo Gastroesofágico/complicaciones , Rechazo de Injerto/complicaciones , Trasplante de Pulmón/efectos adversos , Inhibidores de la Bomba de Protones/uso terapéutico , Adulto , Anciano , Ácidos y Sales Biliares/análisis , Líquido del Lavado Bronquioalveolar/química , Estudios de Casos y Controles , Estudios Transversales , Femenino , Reflujo Gastroesofágico/tratamiento farmacológico , Rechazo de Injerto/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Pepsina A/análisis
7.
J Urol ; 158(1): 45-9, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9186320

RESUMEN

PURPOSE: Although many factors have been considered to predict the outcome after radical nephrectomy, renal cell carcinoma continues to behave unpredictably. In a retrospective study the correlation between microvascular tumor invasion and disease-free survival after surgery for renal cell carcinoma was analyzed. MATERIALS AND METHODS: Between 1980 and 1993, 180 patients (mean age 60 years) were followed for a mean of 52 months after radical or partial nephrectomy for clinically localized renal cell carcinoma. The relevance of microscopic vascular invasion was compared to classical tumor staging, grade and tumor diameter. RESULTS: Microscopic vascular invasion was found in 51 patients (28.3%), including 20 (39.2%) with progression (mean interval to progression 72 months). Of 129 patients with no pathological evidence of microscopic vascular invasion only 8 (6.2%) showed progression at a mean interval of more than 160 months. The difference in disease-free survival as a function of microvascular invasion was statistically highly significant (log rank p < 0.00001) and on multivariate analysis this parameter was by far the most relevant predictor of progression. CONCLUSIONS: In patients who underwent radical nephrectomy for clinically nonmetastatic renal cell carcinoma with microvascular invasion but without lymph node involvement or macroscopic vascular invasion the chance of disease progression is estimated at 45% within 1 year. Microvascular invasion is the single most relevant prognosticator after presumed curative radical nephrectomy for renal cell carcinoma.


Asunto(s)
Carcinoma de Células Renales/patología , Neoplasias Renales/patología , Nefrectomía , Venas Renales , Neoplasias Vasculares/patología , Vena Cava Inferior , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Renales/mortalidad , Carcinoma de Células Renales/cirugía , Niño , Progresión de la Enfermedad , Supervivencia sin Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Renales/mortalidad , Neoplasias Renales/cirugía , Masculino , Persona de Mediana Edad , Análisis Multivariante , Invasividad Neoplásica , Estadificación de Neoplasias , Pronóstico , Estudios Retrospectivos , Neoplasias Vasculares/mortalidad
8.
Microvasc Res ; 51(2): 164-74, 1996 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8778572

RESUMEN

A malignant cell population needs the development of microvessels in order to grow and metastasize. Recently, a role for the p53 gene in the regulation of this angiogenic process has been suggested. Wild-type p53 is involved in the secretion of Trombospondin-1 (TSP-1), an angiogenesis inhibitor. Mutations of the p53 gene cause a downregulation of TSP-1 mRNA in cell lines. Mutant p53 also upregulates the expression of vascular endothelial cell growth factor, a potent angiogenic factor. Together with the reported association of p53 protein overexpression and microvessel density (MVD) in head-and-neck squamous-cell carcinoma, these in vitro findings led us to investigate whether this association would also apply in colorectal adenocarcinomas. Structural changes of the p53 gene are the most frequent observed mutations in colorectal carcinoma and are suspected to be involved in the carcinogenesis at a relatively early stage. Parallel tissue sections from primary colorectal adenocarcinomas were immunostained for CD31, an endothelial cell marker, and with DO7, recognizing both mutant and wild-type p53 protein overexpression. The presence of p53 protein overexpression was found to be significantly associated with high MVD in the vascular hot spots. Our results are in accordance with the in vitro studies on the involvement of p53 in angiogenesis. Mutant p53 might stimulate tumor angiogenesis both indirectly, by augmenting the tumor cell proliferation, and directly, by upregulating angiogenic factors and downregulating angiogenic inhibitors.


Asunto(s)
Adenocarcinoma/irrigación sanguínea , Adenocarcinoma/genética , Neoplasias Colorrectales/irrigación sanguínea , Neoplasias Colorrectales/genética , Proteína p53 Supresora de Tumor/genética , Adenocarcinoma/metabolismo , Anciano , Anciano de 80 o más Años , Neoplasias Colorrectales/metabolismo , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Masculino , Microcirculación/patología , Persona de Mediana Edad , Mutación , Neovascularización Patológica/genética , Pronóstico , Proteína p53 Supresora de Tumor/metabolismo
10.
Eur J Surg Oncol ; 20(6): 696-7, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7995426

RESUMEN

Adenocarcinoma of the urethra is extremely rare, constituting 10 to 20% of all primary urethral malignancies in women. As in men, the squamous carcinoma accounts for 70% of all urethral tumours. Adenocarcinomas are mostly primary lesions, originating from the paraurethral glands. A case is reported about a female patient, presenting with a mucinous urethral adenocarcinoma, presumably secondary to a primary rectal adenocarcinoma.


Asunto(s)
Adenocarcinoma Mucinoso/secundario , Neoplasias del Recto/patología , Neoplasias Uretrales/secundario , Adenocarcinoma Mucinoso/patología , Anciano , Femenino , Humanos , Neoplasias Uretrales/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA